PAR 1.92% 25.5¢ paradigm biopharmaceuticals limited..

Yes does seem to have some good early results for them and yes...

  1. 4,174 Posts.
    lightbulb Created with Sketch. 6652
    Yes does seem to have some good early results for them and yes you are right, we do have the jump in terms of time.

    This one again is a stem cell related treatment. We have discussed the general approach here before, a while ago.

    As I and others have said in the past, it is one to watch and it will no doubt become potential competition as they and others get it refined? It can be patient specific and in the past there have been mixed results with some experiencing AE's and other side effects. A quick review of their initial results does look like they got a good percentage of their patients experiencing positive results in the specific plantar fasciitis area (area where the bone of the heel meets the toes).

    They have a lot more work to do and will involve time, our solution has the benefit of scale (not tailored made for each specific patient, less (very little) chance of rejection by the body etc) along with it's long safety record (though in a different route of administration hence the trials).

    Keep your eyes opened!

    DYOR too.






    Last edited by Mozzarc: 17/02/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.005(1.92%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $261.4K 990.7K

Buyers (Bids)

No. Vol. Price($)
1 9999 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 9445 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.